Who are Benzathine Penicilllin G's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Amoxicillin Pulsatile Release Multiparticluate Sprinkle.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/benzathine-penicilllin-g.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Benzathine Penicilllin G — Competitive Intelligence Brief

Benzathine Penicilllin G (Benzathine Penicilllin G) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Beta-lactam antibiotic (penicillin). Area: Infectious Disease.

phase 3 Beta-lactam antibiotic (penicillin) Penicillin-binding proteins (PBPs); bacterial cell wall peptidoglycan Infectious Disease Small molecule Live · refreshed every 30 min

Target snapshot

Benzathine Penicilllin G (Benzathine Penicilllin G) — Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia. Benzathine penicillin G inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins and preventing peptidoglycan cross-linking.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Benzathine Penicilllin G TARGET	Benzathine Penicilllin G	Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia	phase 3	Beta-lactam antibiotic (penicillin)	Penicillin-binding proteins (PBPs); bacterial cell wall peptidoglycan
Amoxicillin Pulsatile Release Multiparticluate Sprinkle	Amoxicillin Pulsatile Release Multiparticluate Sprinkle	Advancis Pharmaceutical Corporation	phase 3	Beta-lactam antibiotic (penicillin)	Penicillin-binding proteins (PBPs)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Beta-lactam antibiotic (penicillin) class)

Advancis Pharmaceutical Corporation · 1 drug in this class
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Benzathine Penicilllin G — Competitive Intelligence Brief. https://druglandscape.com/ci/benzathine-penicilllin-g. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab